↑↓ navigate ↵ open esc close
SELL TO STATE.
Start free trial
Sweden TED contract award · ocds-ted-107928-2024-6

Sweden – Antineoplastic and immunomodulating agents – Rekvisitionsläkemedel inom ATC-kod L och M 2024 (Sydöstra-Ö)

Region Östergötland awarded a contract of undisclosed value to Immedica Pharma AB for Professional Services & Consulting in February 2024 — one of 613 awards this buyer has made.

Professional Services & Consulting
21 Feb 2024
Award date
Not disclosed
Contract value

Buying agency

Region Östergötland
613 Awards
kr50.8M Avg award

Winning supplier

Immedica Pharma AB
5 Awards
3 Buyers

Contract description

Sweden – Antineoplastic and immunomodulating agents – Rekvisitionsläkemedel inom ATC-kod L och M 2024 (Sydöstra-Ö)

Premium

Related awards · Region Östergötland

613 awards

The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.

Tender no.SupplierAmountDateSector

Full dataset

Unlock the full data.

Subscribe to reveal every row, year-over-year trends, and CSV / API export.

Unlock full dataset →

569 more awards from this buyer · full history & CSV export

Premium

Other wins · Immedica Pharma AB

5 wins

The supplier's complete win history across every buyer it sells to — not just the handful shown here.

Tender no.BuyerAmountDateSector
Locked rows — unlock the full dataset below.

Premium · full dataset

See the full award context.

Competing bids, award margins and every related contract for Region Östergötland and Immedica Pharma AB — one subscription unlocks everything.

Sign Up Free →

Free account · cancel anytime · 14-day money-back

Sign Up